Hugo R. Martinez

Dr. Hugo R. Martinez

Le Bonheur Children's Hospital, Memphis, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Circulation: Cardiovascular Genetics
Verified
Journal Article
Closed access
PDF file
MBMatthew N. Bainbridge
Matthew N. Bainbridge
EDErica Davis
Erica Davis
WCWen-Yee Choi
Wen-Yee Choi
ADAmy Dickson
Amy Dickson
Hugo R. MartinezHugo R. Martinez
Hugo R. Martinez
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies
Background—: Left ventricular noncompaction (LVNC) is an autosomal-dominant, genetically heterogeneous cardiomyopathy with variable severity, which may co-occur with cardiac hypertrophy. Methods and Results—: Here, we generated whole exome sequence data from multiple members from 5 families with LVNC. In 4 of 5 families, the candidate causative mutation segregates with disease in known LVNC genes MYH7 and TPM1 . Subsequent sequencing of MYH7 in a larger LVNC cohort identified 7 novel likely disease causing variants. In the fifth family, we identified a frameshift mutation in NNT , a nuclear-encoded mitochondrial protein, not implicated previously in human cardiomyopathies. Resequencing of NNT in additional LVNC families identified a second likely pathogenic missense allele. Suppression of nnt in zebrafish caused early ventricular malformation and contractility defects, probably driven by altered cardiomyocyte proliferation. In vivo complementation studies showed that mutant human NNT failed to rescue nnt morpholino-induced heart dysfunction, indicating a probable haploinsufficiency mechanism. Conclusions—: Together, our data expand the genetic spectrum of LVNC and demonstrate how the intersection of whole exome sequence with in vivo functional studies can accelerate the identification of genes that drive human genetic disorders.

29 July 2013 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
ACAlana Cecchi
Alana Cecchi
NONaomi Ogawa
Naomi Ogawa
Hugo R. MartinezHugo R. Martinez
Hugo R. Martinez
ACAlicia Carlson
Alicia Carlson
YFYuxin Fan
Yuxin Fan
DMDianna M. Milewicz
Dianna M. Milewicz

18 October 2011 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
Hugo R. MartinezHugo R. Martinez
Hugo R. Martinez
MNMary C. Niu
Mary C. Niu
VSV. Reid Sutton
V. Reid Sutton
RPRicardo Pignatelli
Ricardo Pignatelli
MVMatteo Vatta
Matteo Vatta
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies

1 January 2019 in The Journal of Pediatrics
Verified
Journal Article
Closed access
JHJill C. Handisides
Jill C. Handisides
DHDanielle Hollenbeck-Pringle
Danielle Hollenbeck-Pringle
KUKaren Uzark
Karen Uzark
FTFelicia L. Trachtenberg
Felicia L. Trachtenberg
VPVictoria L. Pemberton
Victoria L. Pemberton
HTHolly Taylor
Holly Taylor

11 April 2011 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
Hugo R. MartinezHugo R. Martinez
Hugo R. Martinez
JBJohn W. Belmont
John W. Belmont
WCWilliam J. Craigen
William J. Craigen
MTMichael D. Taylor
Michael D. Taylor
John Lynn JefferiesJohn Lynn Jefferies
John Lynn Jefferies

1 January 2012 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
JJJohn L. Jefferies
John L. Jefferies
RPRicardo H. Pignatelli
Ricardo H. Pignatelli
Hugo R. MartinezHugo R. Martinez
Hugo R. Martinez
PRPatricia J. Robbins-Furman
Patricia J. Robbins-Furman
PLPengfei Liu
Pengfei Liu
LPLorraine Potocki
Lorraine Potocki
Purpose: Cardiovascular abnormalities are newly recognized features of duplication 17p11.2 syndrome. In a single-center study, we evaluated subjects with duplication 17p11.2 syndrome for cardiovascular abnormalities. Methods: Twenty-five subjects with 17p11.2 duplication identified by chromosome analysis and/or array-based comparative genomic hybridization were enrolled in a multidisciplinary protocol. In our clinical evaluation of these subjects, we performed physical examinations, echocardiography, and electrocardiography. Three of these subjects were followed up longitudinally at our institution. Results: Cardiovascular anomalies, including structural and conduction abnormalities, were identified in 10 of 25 (40%) of subjects with duplication 17p11.2 syndrome. The most frequent abnormality was dilated aortic root (20% of total cohort). Bicommissural aortic valve (2/25), atrial (3/25) and ventricular (2/25) septal defects, and patent foramen ovale (4/25) were also observed. Conclusion: Duplication 17p11.2 syndrome is associated with structural heart disease, aortopathy, and electrocardiographic abnormalities. Individuals with duplication 17p11.2 syndrome should be evaluated by electrocardiography and echocardiography at the time of diagnosis and monitored for cardiovascular disease over time. Further clinical investigation including longitudinal analysis would likely determine the age of onset and characterize the progression (if any) of vasculopathy in subjects with duplication 17p11.2 syndrome, so that specific guidelines can be established for cardiovascular management. Genet Med 2012:14(1):90–94.